Develops cell therapies for cancer.
Dec 2025Revenue $252K/yrExpenses $3.36M/yr
No trend
Figures by year
When will CytoMed Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $252K and expenses $3.36M.
| Fiscal year to | Revenue | Expenses | Pre-tax profit |
|---|---|---|---|
| Dec 2025 | $252K | $3.36M | −$3.11M |
| Dec 2024 | $50.9K | $1.90M | −$1.85M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.